Cited by 24Advanced Drug Delivery SystemsHydrogels: synthesis, properties, applicationsbiodegradable polymer synthesis and properties

Optimization and in vitro evaluation of injectable sustained-release of levothyroxine using PLGA-PEG-PLGA

Open access
Kamali, Hossein, Khodaverdi, Elham, Kaffash, Ehsan, Saffari, Amir Sarem, Shiadeh, Seyedeh Nesa Rezaeian, Nokhodchi, Ali, Hadizadeh, Farzin·2021·Journal of Pharmaceutical Innovation

Abstract

Abstract Purpose In situ-forming gels (semi-solid state) (ISFGs) are widely used as sustained drug delivery, but they show a high burst release as well. The purpose of the current study is to make triblock that can make a quick gel on injection with a minimum burst release. Methods In this study, to control the release of levothyroxine from ISFG, PLGA-PEG-PLGA (triblock) polymer was used. The melting method was employed to synthesize the triblock via ring-opening polymerization (ROP). Different weight percentages of triblock in the formulation were investigated to reach the minimum initial burst release of levothyroxine from ISFGs.Furthermore, the results of the in-situ forming implant (solid-state) (ISFI) of levothyroxine prepared from PLGA 504 H polymers were compared with ISFG. Results The melting method employed in this study showed a successful ROP of the triblock. As the % triblock concentration was increased from 30 to 50%, the initial burst release decreased significantly. The initial burst release levothyroxine from ISFG (6.52 ± 0.30%) was much lower than the amount of levothyroxine released from ISFI (14.15 ± 0.79%). No cytotoxicity was observed for the sustained-release formulation containing ISFG 50% according to the MTT assay. Conclusion The results indicated that this formulation was safe to be administered subcutaneously. As the synthesized triblock has thermosensitive properties, and also has the hydrogen bonding between the N-methyl pyrrolidone molecules and PEG, therefore, these properties make ISFG formulation to have a smaller initial burst release compared to ISFI formulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12247-020-09480-y

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A 50% triblock NMP solution showed the best biocompatibility of all concentrations.

    “Taking cellular toxicity into consideration, a 50% triblock NMP solution showed the best biocompatibility of all concentrations.”
  • A 25 °C to 30 °C transition temperature from sol to gel limits the application of thermosensitive polymers in clinical practice.

    “However, a 25 °C to 30 °C transition temperature from sol to gel limits the application of thermosensitive polymers in clinical practice.”
  • In vitro experiments revealed a 500-hour gradual release of LT4 after a burst release of approximately 20% of the total contents in the first 24 hours for a thermosensitive polymer preparation.

    “In vitro experiments revealed a 500-hour gradual release of LT4 after a burst release of ∼20% of the total contents in the first 24 hours.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kamali, H., Khodaverdi, E., Kaffash, E., Saffari, A. S., Shiadeh, S. N. R., Nokhodchi, A., & Hadizadeh, F.
Affiliations
  • Mashhad University of Medical Sciences (IR)
  • University of Sussex (GB)
Corresponding author
  • Nokhodchi, Ali
  • Hadizadeh, Farzin
Venue
Journal of Pharmaceutical Innovation
Published
2020-08-11
Volume
16
Issue
4
Pages
688-698
ISSN
  • 1872-5120 (ISSN-L)
  • 1939-8042
OpenAlex
W3048673846
Cited by
24
References
53
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 10 · 2021: 4 · 2020: 1
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
Journal of Pharmaceutical Innovation (publishedVersion, cc-by)
Funders
Mashhad University of Medical Sciences (N-961554)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
  • Physical Sciences › Materials Science › Biomaterials › biodegradable polymer synthesis and properties
Keywords
levothyroxine, in situ gel, in situ forming implants, sustained drug release, burst release, ring-opening polymerization, thermoresponsive polymers, subcutaneous injection, cytotoxicity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review